Biocept, Inc. (BIOC)

NASDAQ: BIOC · IEX Real-Time Price · USD
0.964
+0.016 (1.69%)
At close: Jun 29, 2022 4:00 PM
1.000
+0.036 (3.713%)
After-hours: Jun 29, 2022 7:27 PM EDT

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for Biocept stock is $8.16, which predicts an increase of 746.3%. The lowest target is $4.04 and the highest is $12.6. On average, analysts rate Biocept stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $4.04 $8.16 $8.16 $12.6
Change +319.00% +746.30% +746.30% +1206.8%

Analyst Ratings

The average analyst rating for Biocept stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 222222
Buy 555555
Hold 111111
Sell 000000
Strong Sell 000000
Total 888888

Financial Forecast

Revenue This Year
49.01M
Decreased by -19.98%
Revenue Next Year
6.98M
Decreased by -85.77%
EPS This Year
-0.77
EPS Next Year
-1.47
Year 2017201820192020202120222023202420252026
Revenue
5.07M3.25M5.53M27.46M61.25M49.01M6.98M15.60M18.18M21.63M
Revenue Growth
57.26%
-35.87%
70.09%
396.71%
123.04%
-19.98%
-85.77%
123.61%
16.59%
18.92%
EPS
-235.80-90.10-12.23-1.50-0.19-0.77-1.47-1.09-0.71-0.48
EPS Growth
----------
No. Analysts -----44422

Revenue Forecast

Revenue 20222023202420252026
High 56.5M 7.2M 20.4M 19.1M 22.5M
Avg 49.0M 7.0M 15.6M 18.2M 21.6M
Low 41.5M 6.7M 10.9M 17.6M 21.0M

Revenue Growth

Revenue Growth 20222023202420252026
High
-5.2%
-85.3%
192.4%
22.4%
23.7%
Avg
-17.7%
-85.8%
123.6%
16.6%
18.9%
Low
-30.4%
-86.4%
56.8%
13.1%
15.4%

EPS Forecast

EPS 20222023202420252026
High -0.69 -1.47 -1.09 -0.75 -0.49
Avg -0.77 -1.47 -1.09 -0.71 -0.48
Low -0.82 -1.46 -1.07 -0.69 -0.46

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -